01 / Hero

Diagnostics

Objective Diagnostic Technology to Aid Clinical Decisions

FDA-cleared technology that gives you objective data to act on. It aids clinical decisions; it does not replace them. WAVi reads brain function. TM-Flow reads cardiovascular plus autonomic. Max Pulse adds chairside pulse-wave screening, and PreCheckHealth panels add the molecular layer.

Book a call See the evidence

Four tools, one patient

Two main platforms. Two adjacent tools.

WAVi · brain function, EEG and ERP

TM-Flow · cardiovascular plus autonomic

Max Pulse · chairside pulse-wave screening

Genetic Panels · molecular layer via PreCheckHealth

02 / Diagnostics

The Platforms

Two main platforms. Two adjacent tools. One patient.

Two flagship platforms carry the diagnostic load. WAVi (FDA 510(k) K213900) measures brain function through EEG and event-related potentials. TM-Flow (LD Technology, three clearances) reads cardiovascular plus autonomic function in one visit. Both are FDA-cleared and reimbursable. Max Pulse and the PreCheckHealth genetic panels extend the picture without adding billing complexity.

Main platform

Brain · EEG / ERP

WAVi Scan System

Captures EEG and event-related potentials to aid in cognitive assessment, concussion evaluation, and longitudinal brain monitoring. Biannual retest cadence recommended.

When medically necessary $600 to $800 per assessment, typical from aggregated EOB data; varies by payer.

FDA 510(k) K213900 CPT 95999 · 99483

Aid in diagnosisOpen page →

Main platform

TM-Flow System workstation, ANS / SUDO / ABI

Cardio · Autonomic · Vascular

TM-Flow System
(ANS, SUDO, ABI)

One workstation, three modules: autonomic function, sudomotor response, and ankle-brachial index in a single ten-minute visit. Three FDA clearances behind one device.

When medically necessary $300 to $400 per autonomic test, typical from EOB data; varies by payer. Cash-pay $350 to $500.

K173696 · K152216 · K200141 CPT 95921 · 95923 · 93922

LD TechnologyOpen page →

Cardio · Pulse wave

Max Pulse

Chairside pulse-wave screening for cardiovascular and arterial-stiffness markers. Three-to-five-minute test, immediate report. A screening tool, not a replacement for formal cardiac workup.

Positioning Cash-pay / wellness FDA 510(k) K110374. Cash-pay screening positioning.

FDA 510(k) K110374 Cash-pay

Cardiovascular Testing DeviceOpen page →

PreCheckHealth panels + lab visual

Molecular · Patient referral

Genetic Panels
via PreCheckHealth · CLIA + CAP

Four clinical-grade panels: PharmacoCheck+, CancerCheck (116 genes), ImmunoCheck (291 genes), and Comprehensive Neurogenetic (203 genes). Provider-ordered through PreCheckHealth, not direct-to-consumer.

How it works Patient referral Lab bills insurance directly. Clinic adds depth without billing lift.

CLIA + CAP accredited Pharma · Cancer · Immuno · Neuro

PreCheckHealthOpen panel guide →

03 / How It Fits

How It Fits

Baseline. Treat. Retest.

Diagnostics are not a one-time snapshot. They anchor the TITN methodology: capture an objective baseline, treat against what the data shows, then retest to prove what moved. Instead of asking a patient whether they feel better, you show them, and their payer, exactly what changed.

Baseline

FDA-cleared diagnostic captures objective biomarkers: heart rate variability, sudomotor function, brain wave patterns, cognitive processing speed, evoked potentials. Documented before any intervention.

Treat

Evidence-based therapeutic protocol with documented compliance. Could be photobiomodulation, hyperbaric, hydrogen, ALTMS, or a multimodal plan tied to the baseline findings.

Retest

Identical protocol at 4 to 6 weeks (acute) or 12 weeks (chronic). Side-by-side reports show what moved. Billable again within payer frequency limits and medical necessity.

05 / Sources

Sources & verification Every FDA clearance, CPT code, and reimbursement claim on this page traces to a live source. View the sources

Every FDA clearance, CPT code, and reimbursement claim on this page traces to a live primary source: the FDA 510(k) database (openFDA), CMS coverage and fee-schedule pages, and device manufacturers. Reimbursement ranges reflect aggregated explanation-of-benefits data and vary by payer, plan, and locality. All diagnostics aid clinical decisions and do not replace clinical judgment.

WAVi, FDA 510(k) K213900 (WAVi SCAN EEG System), openFDA: api.fda.gov/device/510k.json?search=k_number:K213900
WAVi billing path (panel billed as CPT 95999, one unit): CMS Physician Fee Schedule · 95999 is an unlisted neurological procedure, priced by report, billed as one unit and not unbundled, payer-confirmed
CPT 99483 cognitive assessment and care plan, CMS fee schedule: cms.gov, Cognitive Assessment and Care Plan Services
WAVi clinical and research evidence: wavimed.com/research
TM-Flow ABI module, FDA 510(k) K173696 (LD Technology): api.fda.gov/device/510k.json?search=k_number:K173696
TM-Flow sudomotor module, FDA 510(k) K152216 (LD Technology): api.fda.gov/device/510k.json?search=k_number:K152216
TM-Flow autonomic module, FDA 510(k) K200141 (LD Technology): api.fda.gov/device/510k.json?search=k_number:K200141
TM-Flow clinical studies (ANS, sudomotor, ABI): ldteck.com/studies
Max Pulse, FDA 510(k) K110374 (Max Pulse System, Medicore): api.fda.gov/device/510k.json?search=k_number:K110374
Genetic panels, gene counts, and CLIA #10D2210020 / CAP #9101993: PreCheckHealth

Objective Diagnostic Technology to Aid Clinical Decisions

Two main platforms. Two adjacent tools.

Two main platforms. Two adjacent tools. One patient.

Baseline. Treat. Retest.

Baseline

Treat

Retest

Three ways to start.

Demos coming soon

Book a 15-min call

Request a live demo